PRINCETON, N.J. July 20, 2011 http://www.nextinning.com
McWilliams has been right on target this year with his predictions on the direction of the market. From the spring sell-off to the June rebound to the July slump, McWilliams has stayed one step ahead of the markets with timely reports that have allowed Next Inning subscribers to properly allocate their investments and hedge against risk in a volatile atmosphere. According to McWilliams, there are specific catalysts investors need to watch for to time the next inflection point.
With earnings season now upon us, Next Inning is publishing extensive reports advising which stocks will do well and which investors should avoid going forward. In one of those reports — out earlier this week — McWilliams predicted the upside Apple reported yesterday. In addition, Next Inning subscribers will receive McWilliams’ highly acclaimed State of Tech series, offering in-depth, sector-by-sector coverage of over 65 leading tech companies.
Trial subscribers will also receive real-time trade alerts, daily updates, and frequent, new investing ideas.
To take advantage of this offer and receive these reports for free, please visit the following link:
McWilliams covers these topics and more in his recent reports:
— What are the primary risks facing PMC-Sierra? Is McWilliams expecting PMC-Sierra to significantly exceed analyst expectations this year? Could PMC-Sierra move up by 50% over the next six months?
— Should investors be excited about the two acquisitions that Skyworks has announced this year? How do these acquisitions impact McWilliams’ detailed valuation model for Skyworks? Is Skyworks undervalued at current levels?
— Is Wall Street valuing Celestica at a bargain price? What factors make Celestica a more speculative play than some of the other EMS companies McWilliams covers? Does Celestica merit consideration as an investment with strong potential upside? What other EMS company does McWilliams think should be paired with a long position in Celestica?
About Next Inning:
NOTE: This release was published by Indie Research Advisors, LLC, a registered investment advisor with CRD #131926. Interested parties may visit adviserinfo.sec.gov for additional information. Past performance does not guarantee future results. Investors should always research companies and securities before making any investments. Nothing herein should be construed as an offer or solicitation to buy or sell any security.
SOURCE Indie Research Advisors, LLC